Mirador Capital Partners LP
Source: SEC Form 13F · as of Mar 2026Mirador Capital Partners LP holds 18 biotech & pharma companies tracked by BioSniper, totaling $59.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$59.7M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 65,881 | $14.3M |
| CYTKCYTOKINETICS INC | 202,673 | $13.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 26,115 | $7.1M |
| CLDXCelldex Therapeutics, Inc. | 178,053 | $5.6M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 1,073,236 | $3.8M |
| BMYBRISTOL MYERS SQUIBB CO | 48,870 | $3.0M |
| CAHCardinal Health Inc. | 10,043 | $2.1M |
| GILDGILEAD SCIENCES, INC. | 14,265 | $2.0M |
| JNJJOHNSON & JOHNSON | 7,108 | $1.7M |
| LLYELI LILLY & Co | 1,541 | $1.4M |
| PFEPFIZER INC | 46,410 | $1.3M |
| ABTABBOTT LABORATORIES | 10,508 | $1.1M |
| MRKMerck & Co., Inc. | 5,882 | $708K |
| AXSMAxsome Therapeutics, Inc. | 4,000 | $676K |
| TNYATenaya Therapeutics, Inc. | 886,917 | $614K |
| AMGNAMGEN INC | 1,267 | $446K |
| NVSNovartis AG | 1,874 | $286K |
| PMPhilip Morris International Inc | 1,452 | $240K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.